AI-enhanced MRI analysis revealed more than 10,000 hidden cortical lesions linked to disability and cognitive problems in ...
Teva gains exclusive commercialization rights for IV and SC ocrelizumab biosimilar formulations across the US, Europe, Brazil, Canada, Australia, New Zealand, Israel, and Turkey, pending approvals.
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both ...
I was diagnosed with relapsing-remitting multiple sclerosis (RRMS) at the age of 46.
Daily Mail on MSN
MS breakthrough as researchers find new way to spot previously undetectable brain lesions
Commonly known as MS, multiple sclerosis is a debilitating disease in which the immune system mistakenly attacks the body's ...
A man living with MS has designed an RHS show garden to help others find peace from chronic pain.
Dimitri Garbas, a Greek Australian living with his wife Lisa and their two children in Adelaide, has been fighting a ...
When Allyson Brown’s neurologist told her she would be in a wheelchair by the age of 30, the then 25-year-old PhD student was ...
Teva secures exclusive global rights to commercialize Polpharma Biologics' biosimilar candidate to Ocrevus (ocrelizumab), including both intravenous and subcutaneous formulations. Agreement advances T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results